Patent · US Active

Remedy for diabetes

US9440980B2 · kind B2 · utility

0Cited by
9References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 25, 2014
Grant dateSep 13, 2016
Priority date
Expiry dateApr 25, 2034

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/042
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

A method of screening a compound having a hypoglycemic effect (hereinafter referred to as “hypoglycemic compound”), a remedy for diabetes which contains a compound having a novel function mechanism, etc. More specifically speaking, a method of screening a hypoglycemic compound capable of binding to the β subunit of a trimeric GTP-binding protein, a remedy for diabetes comprising a hypoglycemic compound, which is characterized by being capable of binding to the β subunit of a trimeric GTP-binding protein, as the active ingredient, etc.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.